Schizoaffective Disorder
📧 Sign up to get email alerts when something new happens for Schizoaffective Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-11-29Clinical Trial Update: Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects [Phase 2]
Phase 2 clinical trial evaluating olanzapine in combination with zonisamide sustained-release to prevent weight gain in patients with schizo…
-
CLINICAL_TRIALS trial_result · 2012-11-19Clinical Trial Update: Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone [NA]
A completed clinical trial evaluated diabetes risk factors in people with schizophrenia or bipolar disorder after switching to ziprasidone; …
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia [Phase 4]
Phase 4 trial evaluating ramelteon as an adjunct therapy in non-diabetic patients with schizophrenia and related disorders; results have bee…
-
CLINICAL_TRIALS trial_result · 2012-08-16Clinical Trial Update: A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents [Phase 3]
A Phase 3 clinical trial evaluated lurasidone for the treatment of schizophrenia or schizoaffective disorder in patients switched from other…
-
CLINICAL_TRIALS trial_result · 2012-08-06Clinical Trial Update: A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective Disorder [Phase 4]
This update reports the completion of a Phase 4 clinical trial comparing risperidone with haloperidol in patients with schizophrenia and sch…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Schizophrenic Patients in Integrated Care [Phase 4]
Phase 4 clinical trial sponsored by AstraZeneca evaluating schizophrenia-related conditions was terminated, with results posted in 2012.
-
CLINICAL_TRIALS trial_result · 2012-07-12Clinical Trial Update: Impact of Genetic Counseling for Individuals With Mental Illness [Phase 3]
This Phase 3 trial evaluating the impact of genetic counseling in individuals with schizophrenia, bipolar disorder, and schizoaffective diso…
-
CLINICAL_TRIALS trial_result · 2012-07-09Clinical Trial Update: 24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study [NA]
This completed PET imaging study characterizes the 24-hour time course of striatal D2 receptor occupancy by ziprasidone in schizophrenia and…
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Tetrabenazine for Partial Responders [NA]
A completed clinical trial evaluated tetrabenazine as a treatment option for partial responders with schizophrenia or schizoaffective disord…
-
CLINICAL_TRIALS trial_result · 2012-06-21Clinical Trial Update: Safety, Tolerability, and Pharmacokinetic Study of EVP-6124 in Patients With Schizophrenia [Phase 1]
Phase 1 study evaluating safety, tolerability, and pharmacokinetics of EVP-6124 (encenicline) in schizophrenia and schizoaffective disorder,…
-
CLINICAL_TRIALS trial_result · 2012-06-18Clinical Trial Update: D-Serine for Enhancing Cognitive Retraining for the Treatment of Schizophrenia [Phase 3]
Phase 3 trial evaluating D-Serine as an adjunct to cognitive retraining for schizophrenia has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: Evaluation of the Strategies of Switching Schizophrenia Patients to Aripiprazole From Other Antipsychotic Agents [Phase 4]
Phase 4 clinical trial evaluating strategies for switching schizophrenia patients to aripiprazole from other antipsychotics; status complete…
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Allopurinol in Schizophrenia: A Randomized Trial Administering Allopurinol vs Placebo as add-on Antipsychotics in Patients With Schizophrenia [Phase 4]
Phase 4 randomized trial evaluating add-on allopurinol versus placebo in patients with schizophrenia (including schizoaffective disorder); t…
-
CLINICAL_TRIALS trial_result · 2012-05-03Clinical Trial Update: Cognitive Therapy for Negative Symptoms and Functioning [Phase 2]
Phase 2 study evaluating cognitive therapy to reduce negative symptoms and improve functioning in schizophrenia and schizoaffective disorder…
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Artemisinin to Reduce The Symptoms of Schizophrenia [NA]
An update on a completed clinical trial evaluating artemisinin for reducing symptoms in schizophrenia and schizoaffective disorder; results …
-
CLINICAL_TRIALS trial_result · 2012-02-10Clinical Trial Update: Vitamin D Supplementation in Psychiatric Illnesses [NA]
A completed University of Massachusetts Worcester trial evaluated vitamin D supplementation in people with obesity and vitamin D deficiency …
-
CLINICAL_TRIALS trial_result · 2012-02-07Clinical Trial Update: Efficacy and Safety of Two Atypical Antipsychotics vs. Placebo in Patients With an Acute Exacerbation of Either Schizophrenia or Schizoaffective Disorder [Phase 4]
Phase 4 trial evaluating the efficacy and safety of two atypical antipsychotics versus placebo in acute exacerbations of schizophrenia or sc…
-
CLINICAL_TRIALS trial_result · 2012-01-11Clinical Trial Update: Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder [Phase 3]
Open-label Phase 3 study evaluating intramuscular olanzapine depot in patients with schizophrenia or schizoaffective disorder; results were …
-
CLINICAL_TRIALS trial_result · 2011-11-23Clinical Trial Update: Impact of Genetic Counseling for Female First Degree Relatives of Individuals With Mental Illness [Phase 3]
Phase 3 trial assessing the impact of genetic counseling for female first-degree relatives of individuals with schizophrenia, bipolar disord…
-
CLINICAL_TRIALS trial_result · 2011-10-06Clinical Trial Update: Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia [Phase 3]
This document reports the results of a long-term safety Phase 3 study of lurasidone in clinically stable schizophrenia and schizoaffective d…
-
CLINICAL_TRIALS trial_result · 2011-09-08Clinical Trial Update: Effect of Calories and Fat Content on the Pharmacokinetics of Lurasidone HCl [Phase 1]
This completed Phase 1 pharmacokinetic study investigates how calorie intake and fat content influence the absorption and exposure of lurasi…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS) [NA]
A terminated clinical trial evaluated cognitive outcomes with aripiprazole (Abilify) in patients with schizophrenia (also including schizoaf…
-
CLINICAL_TRIALS trial_result · 2011-09-07Clinical Trial Update: Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI) [NA]
A terminated clinical trial evaluated cognitive outcomes with aripiprazole (Abilify) in patients with schizophrenia and schizoaffective diso…
-
CLINICAL_TRIALS trial_result · 2011-08-03Clinical Trial Update: Specialized Clozapine Clinic for Bipolar and Schizoaffective Disorder
This clinical trial update describes a specialized clozapine clinic for bipolar disorder and schizoaffective disorder. The study status is c…
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective Disorder [Phase 2, Phase 3]
The document reports on a clinical trial studying how ziprasidone affects glucose and lipid parameters in people with diabetes and in those …